These symptoms typically start to fade within a few days or weeks as your body gets used to the medicine
The first month involves a low starting dose (0.25 mg weekly) designed to minimize gastrointestinal side effects and allow the body to adapt to the medication
Main Outcomes and Measures On-treatment weight change in a propensity scorematched population, assessed as hazard of achieving 5% or greater, 10% or greater, and 15% or greater weight loss, and percentage change in weight at 3, 6, and 12 months
HormoneIQ helps us provide individualized care
Same medication Same medical oversight New lower pricing Semaglutide and Tirzepatide work by mimicking a hormone called GLP-1 (and GIP in Tirzepatide), which targets areas in the brain that regulate appetite, satiety, and blood sugar
Clinical studies have shown that weekly Semaglutide injections can lead to an average weight loss of 9-13% over a year when combined with healthy lifestyle habits